BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 29453318)

  • 1. Integration of Distinct ShcA Signaling Complexes Promotes Breast Tumor Growth and Tyrosine Kinase Inhibitor Resistance.
    Ha JR; Ahn R; Smith HW; Sabourin V; Hébert S; Cepeda Cañedo E; Im YK; Kleinman CL; Muller WJ; Ursini-Siegel J
    Mol Cancer Res; 2018 May; 16(5):894-908. PubMed ID: 29453318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival.
    Ursini-Siegel J; Hardy WR; Zheng Y; Ling C; Zuo D; Zhang C; Podmore L; Pawson T; Muller WJ
    Oncogene; 2012 Nov; 31(48):5038-44. PubMed ID: 22286768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer.
    Im YK; Najyb O; Gravel SP; McGuirk S; Ahn R; Avizonis DZ; Chénard V; Sabourin V; Hudson J; Pawson T; Topisirovic I; Pollak M; St-Pierre J; Ursini-Siegel J
    Cancer Res; 2018 Sep; 78(17):4826-4838. PubMed ID: 29930100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.
    Northey JJ; Dong Z; Ngan E; Kaplan A; Hardy WR; Pawson T; Siegel PM
    J Biol Chem; 2013 Feb; 288(7):5210-22. PubMed ID: 23277357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner.
    Im YK; La Selva R; Gandin V; Ha JR; Sabourin V; Sonenberg N; Pawson T; Topisirovic I; Ursini-Siegel J
    Oncogene; 2015 Mar; 34(13):1729-35. PubMed ID: 24837366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.
    Ahn R; Sabourin V; Ha JR; Cory S; Maric G; Im YK; Hardy WR; Zhao H; Park M; Hallett M; Siegel PM; Pawson T; Ursini-Siegel J
    Cancer Res; 2013 Jul; 73(14):4521-32. PubMed ID: 23695548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.
    Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F
    EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression.
    Ahn R; Sabourin V; Bolt AM; Hébert S; Totten S; De Jay N; Festa MC; Young YK; Im YK; Pawson T; Koromilas AE; Muller WJ; Mann KK; Kleinman CL; Ursini-Siegel J
    Nat Commun; 2017 Mar; 8():14638. PubMed ID: 28276425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor.
    Landry M; Pomerleau V; Saucier C
    Biochem J; 2016 Jun; 473(11):1617-27. PubMed ID: 27048591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ShcA signalling is essential for tumour progression in mouse models of human breast cancer.
    Ursini-Siegel J; Hardy WR; Zuo D; Lam SH; Sanguin-Gendreau V; Cardiff RD; Pawson T; Muller WJ
    EMBO J; 2008 Mar; 27(6):910-20. PubMed ID: 18273058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ShcA phosphotyrosine docking protein uses distinct mechanisms to regulate myocyte and global heart function.
    Vanderlaan RD; Hardy WR; Kabir MG; Pasculescu A; Jones N; deTombe PP; Backx PH; Pawson T
    Circ Res; 2011 Jan; 108(2):184-93. PubMed ID: 21148430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential signaling by adaptor molecules LRP1 and ShcA regulates adipogenesis by the insulin-like growth factor-1 receptor.
    Woldt E; Matz RL; Terrand J; Mlih M; Gracia C; Foppolo S; Martin S; Bruban V; Ji J; Velot E; Herz J; Boucher P
    J Biol Chem; 2011 May; 286(19):16775-82. PubMed ID: 21454706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions.
    Pelicci G; Dente L; De Giuseppe A; Verducci-Galletti B; Giuli S; Mele S; Vetriani C; Giorgio M; Pandolfi PP; Cesareni G; Pelicci PG
    Oncogene; 1996 Aug; 13(3):633-41. PubMed ID: 8760305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ShcA adaptor protein is a critical regulator of breast cancer progression.
    Ursini-Siegel J; Muller WJ
    Cell Cycle; 2008 Jul; 7(13):1936-43. PubMed ID: 18604176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ShcA tyrosine phosphorylation sites can replace ShcA binding in signalling by middle T-antigen.
    Nicholson PR; Empereur S; Glover HR; Dilworth SM
    EMBO J; 2001 Nov; 20(22):6337-46. PubMed ID: 11707405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial ShcA docking interactions support diversity in tissue morphogenesis.
    Hardy WR; Li L; Wang Z; Sedy J; Fawcett J; Frank E; Kucera J; Pawson T
    Science; 2007 Jul; 317(5835):251-6. PubMed ID: 17626887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.
    Ursini-Siegel J; Cory S; Zuo D; Hardy WR; Rexhepaj E; Lam S; Schade B; Jirstrom K; Bjur E; Piccirillo CA; Denardo D; Coussens LM; Brennan DJ; Gallagher WM; Park M; Pawson T; Hallett M; Muller WJ
    Cancer Res; 2010 Oct; 70(20):7776-87. PubMed ID: 20924104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ShcA Adaptor Protein Promotes Nephrin Endocytosis and Is Upregulated in Proteinuric Nephropathies.
    Martin CE; Petersen KA; Aoudjit L; Tilak M; Eremina V; Hardy WR; Quaggin SE; Takano T; Jones N
    J Am Soc Nephrol; 2018 Jan; 29(1):92-103. PubMed ID: 29018139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of STS-1 as a novel ShcA-binding protein.
    van der Meulen T; Swarts S; Fischer W; van der Geer P
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1334-1339. PubMed ID: 28690151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.